Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Pinterest Inc (PINS) Price & Performance

Ascendis Pharma A/STrade
Pinterest IncTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Pinterest Inc — how do they compare? Ascendis Pharma A/S trades at $254.76 (market cap $16.67B), while Pinterest Inc trades at $22.94 (market cap $13.45B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.

ASNDPINS
Market Cap
$16.67B$13.45B
Sector
HealthMedia
52-Week High
$277.18$37.95
52-Week Low
$189.74$15.42
Enterprise Value
$17.04B$13.37B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ascendis Pharma A/S

Ascendis Pharma (ASND) trades at $255.50, showing minimal daily movement with a slight decline of 0.05%. The stock maintains a bullish technical outlook with strong moving average signals, while oscillators remain neutral. Fundamentally, the company demonstrates impressive revenue growth from $51M in 2022 to $720M in 2025, though it remains unprofitable with a net loss of $228M. Analyst sentiment is overwhelmingly positive with 92% buy ratings and a $309.75 consensus price target representing 21% upside potential.

ASND presents a compelling growth story with multiple product launches driving revenue expansion, but carries significant execution risk as the company transitions to profitability. The negative shareholder equity and high debt levels require careful monitoring, though positive cash flow generation in 2025 marks an important inflection point. The stock's premium valuation reflects expectations for continued growth in its rare endocrine franchise.

Pinterest Inc

Pinterest (PINS) trades at $22.90, down 6.03% over 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.43, beating estimates of $0.36, driven by 18% revenue growth and record monthly active users. However, the stock faces pressure from lukewarm Q3 revenue guidance and competitive ad market concerns.

The outlook remains positive with strong analyst support—54% recommend Buy—and a $28.69 consensus price target implying 25% upside. Key risks include intense advertising competition and potential growth deceleration, but fundamentals are solid with revenue climbing to $4.22B in 2025 and a robust 79.47% gross margin.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Pinterest Inc

Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.

Read more on PINS